MicroPort®️ EP Holds Live Procedures for the First Time in an Overseas Market

Madrid, Spain, 25 March, 2021 — Shanghai MicroPort EP MedTech Co., Ltd. (“MicroPort® EP”), recently offered live procedure webcasts for the first time in an overseas market, whereby a team of physicians from Spain successfully performed two atrial flutter ablation procedures and two bypass tract ablation procedures. The procedures, which were viewed by a group of physicians in the Dominican Republic via online streaming, were carried out using MicroPort® EP’s Columbus® 3D EP Navigation System (“Columbus®”) and supporting catheters.

During these procedures, Dr. Merino’s team in Spain used the PathBuilder® Introducer to complete the atrial septal puncture and successfully performed ablation guided by Columbus®. Dr. Merino positively evaluated the smooth performance of the PathBuilder® during puncture, and recognized the easy-use interface and stability of Columbus®. After observing the full and detailed procedure through the live broadcast, the physicians from the Dominican Republic were able to appreciate the fast modeling and mapping features of Columbus®, noting that the entire ablation becomes easier and more efficient by using the system.

Dr. Yiyong Sun, President of MicroPort® EP, said, “The integrated EP solution provided by MicroPort® EP has served overseas markets such as Europe, South America and Southeast Asia, and has been widely recognized by experts in clinical applications. The overseas webcasts are a valuable initiative and we will further utilize online platforms to facilitate the academic exchange of new ideas and therapies among physicians worldwide, to promote quality and inclusive therapies, and provide better products and services for patients and doctors alike.”

Columbus® is designed to diagnose and treat complex arrhythmias. Compared to traditional catheter ablation guided by X-ray fluoroscopy, Columbus® not only combines intracardiac electrical signals with spatial structures to help physicians complete catheter ablation of complex arrhythmias, but also greatly reduces radiation exposure and procedure time for patients and physicians.

These procedures do not mark the first use of Columbus® in Spain, as the system has previously been used successfully by local experts to explore new mapping methods for atrial fibrillation ablation.

About MicroPort® EP

Shanghai MicroPort EP MedTech Co., Ltd, a subsidiary of MicroPort Scientific Corporation (MicroPort®, stock code: 00853.HK), was established in the Shanghai International Medical Zone on August 31, 2010. Its concentration is on the development, manufacture, and marketing of minimally invasive medical devices for the treatment of electrophysiological diseases, including cardiac ablation catheters, diagnostic catheters, 3D navigation systems, amongst others.